id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2004-D-0122-0003,FDA,FDA-2004-D-0122,See FDA-2004-D-0122-0002,Supporting & Related Material,GDL-Guidance,2004-12-23T05:00:00Z,2004,12,,,2009-05-11T15:47:27Z,,0,0,090000648046fbc1
FDA-2004-D-0122-0002,FDA,FDA-2004-D-0122,Compliance Guidance for Small Business Entities on Labeling Over-the-Counter Human Drug Products; Draft Guidance,Other,GDL-Guidance (Supporting and Related Materials),2004-12-23T05:00:00Z,2004,12,,,2013-08-11T04:06:32Z,,0,0,090000648046fbbe
FDA-2004-D-0122-0001,FDA,FDA-2004-D-0122,Draft Compliance Guidance for Small Business Entities on Labeling Over-the-Counter Human Drug Products; Availability,Notice,NAD-Notice of Availability of Data,2004-12-23T05:00:00Z,2004,12,2004-12-08T05:00:00Z,2005-02-08T04:59:59Z,2009-05-11T15:38:00Z,,0,0,090000648046fbbc
FDA-2004-D-0122-0004,FDA,FDA-2004-D-0122,See FDA-2004-D-0122-0002,Supporting & Related Material,GDL-Guidance,2004-12-23T05:00:00Z,2004,12,,,2009-05-11T15:46:51Z,,0,0,090000648046fbc2